Learn More
MedChemExpress LSKL, Inhibitor of Thrombospondin (TSP-1)
Description
LSKL, Inhibitor of Thrombospondin (TSP-1) inhibits the binding of TSP-1 to LAP and alleviates renal interstitial fibrosis and hepatic fibrosis. LSKL, Inhibitor of Thrombospondin (TSP-1) suppresses subarachnoid fibrosis via inhibition of TSP-1-mediated TGF-β1 activity, prevents the development of chronic hydrocephalus and improves long-term neurocognitive defects following subarachnoid hemorrhage (SAH). LSKL, Inhibitor of Thrombospondin (TSP-1) can readily crosse the blood-brain barrier.
Specifications
Specifications
| CAS | 283609-79-0 |
| Content And Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| For Use With (Application) | Cancer-Kinase/protease |
| Molecular Weight (g/mol) | 458.6 g/mol |
| Product Type | Peptides |
| Quantity | 25 mg |
| Shipping Condition | Room temperature |
| Solubility | DMSO : ≥ 100 mg/mL (218.05 mM) ∣H2O : 50 mg/mL (109.03 mM∣Need ultrasonic) |
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.